MacCollin M, Chiocca E A, Evans D G, Friedman J M, Horvitz R, Jaramillo D, Lev M, Mautner V F, Niimura M, Plotkin S R, Sang C N, Stemmer-Rachamimov A, Roach E S
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Neurology. 2005 Jun 14;64(11):1838-45. doi: 10.1212/01.WNL.0000163982.78900.AD.
The neurofibromatoses are a diverse group of genetic conditions that share a predisposition to the development of tumors of the nerve sheath. Schwannomatosis is a recently recognized third major form of neurofibromatosis (NF) that causes multiple schwannomas without vestibular tumors diagnostic of NF2. Patients with schwannomatosis represent 2.4 to 5% of all patients requiring schwannoma resection and approximately one third of patients with schwannomatosis have anatomically localized disease with tumors limited to a single limb or segment of spine. Epidemiologic studies suggest that schwannomatosis is as common as NF2, but that familial occurrence is inexplicably rare. Patients with schwannomatosis overwhelmingly present with pain, and pain remains the primary clinical problem and indication for surgery. Diagnostic criteria for schwannomatosis are needed for both clinicians and researchers, but final diagnostic certainly will await the identification of the schwannomatosis locus itself.
神经纤维瘤病是一组多样的遗传疾病,都有易患神经鞘瘤的倾向。施万细胞瘤病是最近确认的神经纤维瘤病(NF)的第三种主要类型,可导致多发施万细胞瘤,且无诊断为NF2的前庭肿瘤。施万细胞瘤病患者占所有需要切除施万细胞瘤患者的2.4%至5%,约三分之一的施万细胞瘤病患者有解剖学上局限性的疾病,肿瘤局限于单个肢体或脊柱节段。流行病学研究表明,施万细胞瘤病与NF2一样常见,但家族性发病却出奇地罕见。施万细胞瘤病患者绝大多数表现为疼痛,疼痛仍然是主要的临床问题和手术指征。临床医生和研究人员都需要施万细胞瘤病的诊断标准,但最终诊断肯定要等到施万细胞瘤病基因座本身被确定。